 |
|
 |
 |
|
||||||||||||||
Acomplia's sale could exceed $3 billion dollars August 31, 2005 The French pharmaceutical group Sanofi-Aventis submitted the new anti obesity drug Acomplia to regulators for marketing approval. It is believed that the sale of Acomplia drug which can also help patients quit smoking can exceed $ 3 billion. The pharmacy group was created by Sanofi-Synthelabo after the takeover of Aventis last August. Though Sanofi was closed on giving more information about Acomplia, it did announce that the company would move four of its drugs to the third phase of clinical trials next year. Acomplia also faces competition from other key obesity drug manufacturers. The new drug is expected to be launched in 2006. Read the complete news story here: http://news.moneycentral.msn.com
|
||||||||||||||
